Attitudes toward end-of-life care for cancer patients vary, but most patients, family members, oncologists and members of the public are receptive to withdrawing futile life-sustaining treatments in people who are dying, found a Korean study in CMAJ (Canadian Medical Association Journal)...
Mouse Genome Dilemma Solved: Data Will Help Scientists Worldwide Design Better Experiments
5/30/2011
Laboratory research has always been limited in terms of what conclusions scientists can safely extrapolate from animal experiments to the human population as a whole...
Novel Pathway Regulating Angiogenesis May Fight Retinal Disease, Cancers
5/30/2011
Scientists identify in the journal Nature a new molecular pathway used to suppress blood vessel branching in the developing retina - a finding with potential therapeutic value for fighting diseases of the retina and a variety of cancers. Researchers report that myeloid cells, blood cells involved in the immune system, use this molecular pathway to guide blood vessel patterning in the retina...
Folic acid supplements given to pregnant and breast-feeding rats reduced the rate of colon cancer in their offspring by 64 per cent, a new study has found. The research, led by Dr. Young-in Kim, a gastroenterologist at St...
$4.7-Million Study On Early-Stage Oral Cancer
5/30/2011
Researchers from UBC's Faculties of Medicine, Science and Dentistry are leading a $4.7 million pan-Canadian clinical trial aimed at improving outcomes for patients undergoing surgery for oral squamous cell cancers...
Two Joint Research Laboratories To Be Created In France By The Helmholtz Association And Inserm
5/30/2011
Inserm and the German Helmholtz Association announce the creation of two Franco-German joint research laboratories to promote interaction between their researchers and to foster the establishment of a new form of cooperation in life sciences and health between the two countries...
Protect Your Skin - Don't Go Red On "Don't Fry Day"
5/29/2011
Friday before Memorial Day has been declared "Don't Fry Day" by the National Council on Skin Cancer Prevention. The aim is to drastically bring down the rate of skin cancer in the United States, where one person dies every hour from skin cancer, according to the American Cancer Society...
Scientists identify in the journal Nature a new molecular pathway used to suppress blood vessel branching in the developing retina - a finding with potential therapeutic value for fighting diseases of the retina and a variety of cancers. Researchers report that myeloid cells, blood cells involved in the immune system, use this molecular pathway to guide blood vessel patterning in the retina...
No Overall Increased Cancer Risk Found For Arthritis Patients Taking Newer Treatments
5/29/2011
Only three percent (n=181) of patients in the study cohort receiving anti-tumour necrosis factor agents (anti-TNFs) for treatment of their arthritis developed a first cancer within nine years and overall risk was not dependent on the type of arthritis. The nine year follow-up study conducted at Gentofte University Hospital, Denmark demonstrated that relative risk ((RR)=1...
New Drug Treatment Extends Lives Of Men With Prostate Cancer
5/29/2011
A drug recently approved by the Food & Drug Administration for the treatment of prostate cancer is proving to give some patients the gift of time. A new study shows abiraterone acetate extends the lives of men with the most advanced form of the disease by about four months. The study in the May 26, 2011 issue of the New England Journal of Medicine was co-authored by Thomas W...